Clinical Trial Update: Oral Pirfenidone for the Pulmonary Fibrosis of Hermansky-Pudlak Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial of oral pirfenidone for Hermansky-Pudlak syndrome-associated pulmonary fibrosis has completed and results have been posted. The study evaluates pi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Albinism
• Hermansky-pudlak Syndrome
• Oculocutaneous Albinism
• Platelet Storage Pool Deficiency
• Pulmonary Fibrosis

Drugs mentioned

• Esbriet (pirfenidone)

Snippet

Sponsor: William Gahl, M.D. | Conditions: Albinism, Inborn Errors of Metabolism | Phase 2 | Status: COMPLETED | Results posted: 2012-01-26